Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Ischemic Heart Disease

Free Subscription Articles published in Eur Heart J Retrieve available abstracts of 370 articles: HTML format

Single Articles

May 2024
1. PAOLUCCI L, Mangiacapra F, Sergio S, Nusca A, et al
   Periprocedural myocardial infarction after percutaneous coronary intervention and long-term mortality: a meta-analysis.
   Eur Heart J. 2024 May 14:ehae266. doi: 10.1093.
   PubMed     Abstract available
   
   
   
2. CREA F
   Focus on ischaemic heart disease: prevention with colchicine, role of the brain-heart axis, new therapeutic targets for ischaemia-reperfusion injury.
   Eur Heart J. 2024;45:1577-1581.
   PubMed    
   
   
   
3. TAKAHARA M, Soga Y, Iida O
   Lower extremity arterial disease vs. coronary artery disease: mortality differences after revascularization.
   Eur Heart J. 2024;45:1634-1643.
   PubMed     Abstract available
   
   
   
4. AMPONSAH-OFFEH M, Tual-Chalot S, Stellos K
   Repurposing of an antiasthmatic drug may reduce NETosis and myocardial ischaemia/reperfusion injury.
   Eur Heart J. 2024;45:1681-1683.
   PubMed    
   
   
   
5. YANG K, Gao R, Chen H, Hu J, et al
   Myocardial reperfusion injury exacerbation due to ALDH2 deficiency is mediated by neutrophil extracellular traps and prevented by leukotriene C4 inhibition.
   Eur Heart J. 2024;45:1662-1680.
   PubMed     Abstract available
   
   
   
6. ADLAM D, van Dijk FS, Loeys B
   Genetic testing in patients with unexplained coronary aneurysms or dilation.
   Eur Heart J. 2024;45:1610-1612.
   PubMed    
   
   
   
7. JONES DA, Beirne AM, Kelham M, Wynne L, et al
   Inorganic nitrate benefits contrast-induced nephropathy after coronary angiography for acute coronary syndromes: the NITRATE-CIN trial.
   Eur Heart J. 2024;45:1647-1658.
   PubMed     Abstract available
   
   
   
8. XIAO Q, Xu Y, Wang S
   Gastropericardial fistula complicated by severe multi-vessel coronary spasm.
   Eur Heart J. 2024;45:1685.
   PubMed    
   
   
   
9. CHEN Z, Dazard JE, Khalifa Y, Motairek I, et al
   Artificial intelligence-based assessment of built environment from Google Street View and coronary artery disease prevalence.
   Eur Heart J. 2024;45:1540-1549.
   PubMed     Abstract available
   
   
   
10. HEUSCH G, Kleinbongard P
    Cardioprotection research has left its comfort zone.
    Eur Heart J. 2024;45:1568-1570.
    PubMed    
    
    
    April 2024
11. GALIUTO L, Volpe M
    Weekly journal scan: excess incidence of unexpected health outcomes following myocardial infarction-broader paths for secondary prevention.
    Eur Heart J. 2024 Apr 15:ehae229. doi: 10.1093.
    PubMed    
    
    
    
12. BHATT AS, Johansen ND, Modin D, Claggett BL, et al
    Electronic nudges increase influenza vaccination utilization after myocardial infarction: the nationwide NUDGE-FLU implementation trial.
    Eur Heart J. 2024 Apr 10:ehae235. doi: 10.1093.
    PubMed    
    
    
    
13. CREA F
    The complex interaction between cancer, ischaemic heart disease, and heart failure, and a focus on arrhythmias including risk stratification in Brugada syndrome and leadless pacing.
    Eur Heart J. 2024;45:1183-1187.
    PubMed    
    
    
    
14. KASKI JC, Al-Lamee R, Boden WE
    The year in cardiovascular medicine 2023: the top 10 papers in ischaemic heart disease.
    Eur Heart J. 2024;45:1201-1204.
    PubMed    
    
    
    
15. AMERI P, Bertero E, Lombardi M, Porto I, et al
    Ischaemic heart disease in patients with cancer.
    Eur Heart J. 2024;45:1209-1223.
    PubMed     Abstract available
    
    
    
16. BYRNE R, Coughlan JJ, Rossello X, Ibanez B, et al
    The '10 commandments' for the 2023 ESC Guidelines for the management of acute coronary syndromes.
    Eur Heart J. 2024;45:1193-1195.
    PubMed    
    
    
    
17. CALLEGARI A, Bonnet D, Malekzadeh-Milani S
    Successful percutaneous treatment of perinatal complete left coronary thrombotic occlusion.
    Eur Heart J. 2024;45:1285.
    PubMed    
    
    
    
18. WU VC, Yeh JK, Chen SW, Wu CL, et al
    Syphilis and cardiovascular risk: a Taiwanese registry.
    Eur Heart J. 2024 Apr 3:ehae183. doi: 10.1093.
    PubMed     Abstract available
    
    
    
19. SAYAH N, Bhatt DL, Miller M, Brinton EA, et al
    Icosapent ethyl following acute coronary syndrome: the REDUCE-IT trial.
    Eur Heart J. 2024;45:1173-1176.
    PubMed    
    
    
    March 2024
20. WYLD M, Webster AC
    Myocardial infarction and stroke in patients with kidney failure: can we do better?
    Eur Heart J. 2024 Mar 27:ehae153. doi: 10.1093.
    PubMed    
    
    
    
21. TSUDA K, Nagamatsu W, Morii I
    A collateral channel from the bronchial artery in chronic total occlusion of proximal right coronary artery.
    Eur Heart J. 2024;45:1087.
    PubMed    
    
    
    
22. VILAHUR G, Radike M, Sutelman P, Ben-Aicha S, et al
    Recombinant human soluble domain of CD39L3 and ticagrelor: cardioprotective effects in experimental myocardial infarction.
    Eur Heart J. 2024 Mar 15:ehae107. doi: 10.1093.
    PubMed     Abstract available
    
    
    
23. URSO S, Sadaba R, Dayan V
    Benefits of coronary artery bypass grafting over percutaneous coronary intervention in left main disease: the strength of the evidence.
    Eur Heart J. 2024 Mar 5:ehae135. doi: 10.1093.
    PubMed    
    
    
    
24. VERGALLO R, Galiuto L
    Weekly journal scan: do biodegradable polymer stents provide a durable benefit in patients with ST-segment elevation myocardial infarction?
    Eur Heart J. 2024 Mar 4:ehae119. doi: 10.1093.
    PubMed    
    
    
    
25. GALLACHER PJ, Yeung D, Bell S, Shah ASV, et al
    Kidney replacement therapy: trends in incidence, treatment, and outcomes of myocardial infarction and stroke in a nationwide Scottish study.
    Eur Heart J. 2024 Mar 1:ehae080. doi: 10.1093.
    PubMed     Abstract available
    
    
    
26. CREA F
    Ischaemic heart disease: prevention, management, mechanisms, and new therapeutic targets.
    Eur Heart J. 2024;45:637-641.
    PubMed    
    
    
    
27. JANSEN TPJ, Wentzel JJ, Damman P
    Interplay between coronary bridging and high shear stress in the emergence of coronary vasospasm.
    Eur Heart J. 2024;45:737.
    PubMed    
    
    
    February 2024
28. KUMAR A, Vora K, Bhatt DL, Dharmakumar R, et al
    The Canadian Cardiovascular Society Classification of acute atherothrombotic myocardial infarction provides a novel staging scheme based on tissue injury severity.
    Eur Heart J. 2024 Feb 17:ehad821. doi: 10.1093.
    PubMed    
    
    
    
29. TARANTINI G, Putorti F, Nai Fovino L
    10-Year optical coherence tomography follow-up of 'full-plastic jacket' with bioresorbable vascular scaffolds.
    Eur Heart J. 2024;45:556.
    PubMed    
    
    
    
30. BARILE L, Marban E
    Injury minimization after myocardial infarction: focus on extracellular vesicles.
    Eur Heart J. 2024 Feb 15:ehae089. doi: 10.1093.
    PubMed     Abstract available
    
    
    
31. NISHIHIRA K, Asano Y, Shibata Y
    Efficacy of paclitaxel-coated balloon angioplasty combined with intensive lipid-lowering therapy for ST-segment elevation myocardial infarction: insights from near-infrared spectroscopy.
    Eur Heart J. 2024 Feb 15:ehae073. doi: 10.1093.
    PubMed    
    
    
    
32. HOLT A, Nouhravesh N, Strange JE, Kinnberg Nielsen S, et al
    Cannabis for chronic pain: cardiovascular safety in a nationwide Danish study.
    Eur Heart J. 2024;45:475-484.
    PubMed     Abstract available
    
    
    
33. MONTONE RA, Camilli M, Calvieri C, Magnani G, et al
    Exposome in ischaemic heart disease: beyond traditional risk factors.
    Eur Heart J. 2024;45:419-438.
    PubMed     Abstract available
    
    
    
34. CHEONG HS, Chang Y, Kim Y, Kwon MJ, et al
    Human papillomavirus infection and cardiovascular mortality: a cohort study.
    Eur Heart J. 2024 Feb 7:ehae020. doi: 10.1093.
    PubMed     Abstract available
    
    
    
35. THYREGOD HGH, Jorgensen TH, Ihlemann N, Steinbruchel DA, et al
    Transcatheter or surgical aortic valve implantation: 10-year outcomes of the NOTION trial.
    Eur Heart J. 2024 Feb 7:ehae043. doi: 10.1093.
    PubMed     Abstract available
    
    
    
36. BOERHOUT CKM, Piek JJ, van de Hoef TP
    The microvascular resistance reserve: one size fits all, but mostly one.
    Eur Heart J. 2024;45:401.
    PubMed    
    
    
    
37. JANSEN TPJ, Crooijmans C, Damman P
    Microvascular resistance reserve, does one size fit all?
    Eur Heart J. 2024;45:399-400.
    PubMed    
    
    
    January 2024
38. HUET F, Mariano-Goulart D, Aguilhon S, Delbaere Q, et al
    Colchicine to prevent sympathetic denervation after acute myocardial infarction: the COLD-MI trial.
    Eur Heart J. 2024 Jan 30:ehae042. doi: 10.1093.
    PubMed    
    
    
    
39. SENIOR R, Khattar RS
    To test or not to test for ischaemia routinely after percutaneous coronary intervention in diabetic patients: is the jury still out?
    Eur Heart J. 2024 Jan 30:ehad877. doi: 10.1093.
    PubMed    
    
    
    
40. NAKAJIMA A, Okutsu M, Nakamura S
    Optical coherence tomographic patterns of restenosis in patients treated with directional coronary atherectomy and drug-coated balloon therapy.
    Eur Heart J. 2024;45:315.
    PubMed    
    
    
    
41. NATARAJAN N, Dutta P
    'Training' of innate immunity following myocardial infarction exacerbates atherosclerosis.
    Eur Heart J. 2024 Jan 25:ehae024. doi: 10.1093.
    PubMed    
    
    
    
42. GOBEIL E, Bourgault J, Mitchell PL, Houessou U, et al
    Genetic inhibition of angiopoietin-like protein-3, lipids, and cardiometabolic risk.
    Eur Heart J. 2024 Jan 19:ehad845. doi: 10.1093.
    PubMed     Abstract available
    
    
    
43. ARNOLD N, Blaum C, Gossling A, Brunner FJ, et al
    C-reactive protein modifies lipoprotein(a)-related risk for coronary heart disease: the BiomarCaRE project.
    Eur Heart J. 2024 Jan 18:ehad867. doi: 10.1093.
    PubMed     Abstract available
    
    
    
44. VERGALLO R, Galiuto L
    Shedding the optical coherence tomography light on the treatment of complex coronary bifurcation lesions.
    Eur Heart J. 2024;45:159-160.
    PubMed    
    
    
    
45. GOULD KL, Johnson NP, Roby AE, Bui L, et al
    Coronary flow capacity and survival prediction after revascularization: physiological basis and clinical implications.
    Eur Heart J. 2024;45:181-194.
    PubMed     Abstract available
    
    
    
46. SHIMADA T, Otsuka K, Fukuda D
    Acute thrombus formation following stent implantation diagnosed by using intravascular polarimetry.
    Eur Heart J. 2024;45:145.
    PubMed    
    
    
    
47. CAMARO C, Aarts GWA, van Royen N
    Less concern about missing NSTEMIs, more prospective randomized controlled trials warranted.
    Eur Heart J. 2024;45:144.
    PubMed    
    
    
    
48. GLAESER J, Lopez-Ayala P, Mueller C
    Concern regarding missed non-ST-segment elevation myocardial infarctions when applying a single, pre-hospital cardiac troponin measurement.
    Eur Heart J. 2024;45:142-143.
    PubMed    
    
    
    
49. CREA F
    The key role of thrombosis: focus on acute coronary syndrome, venous thrombo-embolism, and atrial fibrillation.
    Eur Heart J. 2024;45:1-4.
    PubMed    
    
    
    
50. BAATEN CCFMJ, Nagy M, Bergmeier W, Spronk HMH, et al
    Platelet biology and function: plaque erosion vs. rupture.
    Eur Heart J. 2024;45:18-31.
    PubMed     Abstract available
    
    
    December 2023
51. TAQUETI VR
    Leveraging global coronary flow assessments to inform revascularization benefit in chronic coronary disease: time to test total heart flow.
    Eur Heart J. 2023 Dec 28:ehad812. doi: 10.1093.
    PubMed    
    
    
    
52. PEDICINO D, Vergallo R
    More blood for patients with myocardial infarction and anaemia?
    Eur Heart J. 2023 Dec 23:ehad832. doi: 10.1093.
    PubMed    
    
    
    
53. REDD MA, Yoshikawa Y, Khan N, Waqar M, et al
    Acid-sensing ion channel 1a blockade reduces myocardial injury in rodent models of myocardial infarction.
    Eur Heart J. 2023 Dec 14:ehad793. doi: 10.1093.
    PubMed    
    
    
    
54. PIRIOU PG, Plessis J, Guerin P
    Transcatheter aortic valve replacement in patients with cardiogenic shock: safe and effective, but the most critical patients require further investigations.
    Eur Heart J. 2023 Dec 14:ehad808. doi: 10.1093.
    PubMed    
    
    
    
55. DONG Z, Hou L, Luo W, Pan LH, et al
    Myocardial infarction drives trained immunity of monocytes, accelerating atherosclerosis.
    Eur Heart J. 2023 Dec 12:ehad787. doi: 10.1093.
    PubMed     Abstract available
    
    
    
56. KHAN MS, Usman MS, Van Spall HGC, Greene SJ, et al
    Endpoint adjudication in cardiovascular clinical trials.
    Eur Heart J. 2023;44:4835-4846.
    PubMed     Abstract available
    
    
    
57. ALFONSO F, Marschall A, Rivero F
    Revascularization for left main coronary artery disease.
    Eur Heart J. 2023;44:4893.
    PubMed    
    
    
    
58. PERSSON J, Ivert T, Omerovic E
    Observational studies are needed to complete the body of evidence for left main coronary artery disease revascularization strategies.
    Eur Heart J. 2023;44:4894.
    PubMed    
    
    
    November 2023
59. LU ZN, Yang Y, Song G
    A patient-tailored clipping strategy of transcatheter edge-to-edge repair as salvage for cardiogenic shock complicated by mitral valve cleft and bileaflet flails.
    Eur Heart J. 2023 Nov 29:ehad802. doi: 10.1093.
    PubMed    
    
    
    
60. VERGALLO R, Volpe M
    Optical coherence tomography to guide percutaneous coronary intervention: is the glass half full or half empty?
    Eur Heart J. 2023 Nov 28:ehad792. doi: 10.1093.
    PubMed    
    
    
    
61. WENZL FA, Fox KAA, Luscher TF
    Towards personalized cardiovascular care: Global Registry of Acute Coronary Events 3.0 score heralds artificial intelligence era.
    Eur Heart J. 2023;44:4615-4616.
    PubMed    
    
    
    
62. PEDICINO D, Vergallo R
    Routine use of extracorporeal life support in cardiogenic shock after acute myocardial infarction: the jury is still out.
    Eur Heart J. 2023 Nov 18:ehad760. doi: 10.1093.
    PubMed    
    
    
    
63. PEDICINO D, Liuzzo G
    Does MULTISTARS shed light on the timing of complete revascularization in ST-elevation myocardial infarction?
    Eur Heart J. 2023 Nov 18:ehad733. doi: 10.1093.
    PubMed    
    
    
    
64. LIU W, Song B, Li B
    Myocardial infarction caused by in situ thrombosis of a patent foramen ovale assessed by optical coherence tomography.
    Eur Heart J. 2023 Nov 15:ehad753. doi: 10.1093.
    PubMed    
    
    
    
65. HENRY CM, Oseran AS, Zheng Z, Dong H, et al
    Cardiovascular Hospitalizations and Mortality Among Adults Aged 25 to 64 years in the United States.
    Eur Heart J. 2023 Nov 11:ehad772. doi: 10.1093.
    PubMed     Abstract available
    
    
    
66. LUO J, Thomassen JQ, Nordestgaard BG, Tybjaerg-Hansen A, et al
    Neutrophil counts and cardiovascular disease.
    Eur Heart J. 2023 Nov 9:ehad649. doi: 10.1093.
    PubMed     Abstract available
    
    
    
67. DEMIDOVA MM, Holmqvist F, Erlinge D, Platonov PG, et al
    Ventricular arrhythmias during ST-segment elevation myocardial infarction and arrhythmic complications during recurrent ischaemic events.
    Eur Heart J. 2023 Nov 3:ehad740. doi: 10.1093.
    PubMed    
    
    
    
68. KIM H, Kang DY, Lee J, Choi Y, et al
    Routine stress testing in diabetic patients after percutaneous coronary intervention: the POST-PCI trial.
    Eur Heart J. 2023 Nov 2:ehad722. doi: 10.1093.
    PubMed     Abstract available
    
    
    
69. CREA F
    Hot topics in interventional cardiology: left main disease, heavily calcified coronary stenoses, and physiology-guided percutaneous coronary interventions.
    Eur Heart J. 2023;44:4295-4299.
    PubMed    
    
    
    
70. ALASNAG M
    Instantaneous wave-free ratio compared with fractional flow reserve: time for rethinking current recommendations.
    Eur Heart J. 2023;44:4385-4387.
    PubMed    
    
    
    
71. BYRNE RA, Fremes S, Capodanno D, Czerny M, et al
    2022 Joint ESC/EACTS review of the 2018 guideline recommendations on the revascularization of left main coronary artery disease in patients at low surgical risk and anatomy suitable for PCI or CABG.
    Eur Heart J. 2023;44:4310-4320.
    PubMed     Abstract available
    
    
    
72. JOHNSON NP, Ahn JM
    Left main PCI: beware the circumflex!
    Eur Heart J. 2023;44:4337-4339.
    PubMed    
    
    
    
73. BARBATO E, Gallinoro E, Abdel-Wahab M, Andreini D, et al
    Management strategies for heavily calcified coronary stenoses: an EAPCI clinical consensus statement in collaboration with the EURO4C-PCR group.
    Eur Heart J. 2023;44:4340-4356.
    PubMed     Abstract available
    
    
    
74. WANG HY, Zhang R, Dou K, Huang Y, et al
    Left main bifurcation stenting: impact of residual ischaemia on cardiovascular mortality.
    Eur Heart J. 2023;44:4324-4336.
    PubMed     Abstract available
    
    
    October 2023
75. NAMBIEMA A, Lisan Q, Vaucher J, Perier MC, et al
    Healthy sleep score changes and incident cardiovascular disease in European prospective community-based cohorts.
    Eur Heart J. 2023 Oct 20:ehad657. doi: 10.1093.
    PubMed     Abstract available
    
    
    
76. ARORA S, Zimmermann FM, Solberg OG, Nytroen K, et al
    Prognostic value of intravascular ultrasound early after heart transplantation.
    Eur Heart J. 2023 Oct 18:ehad648. doi: 10.1093.
    PubMed    
    
    
    
77. CREA F
    Acute coronary syndromes: new guidelines and new light shed on biomarkers and mechanisms of plaque instability.
    Eur Heart J. 2023;44:3707-3711.
    PubMed    
    
    
    
78. WENZL FA, Bruno F, Kraler S, Klingenberg R, et al
    Dipeptidyl peptidase 3 plasma levels predict cardiogenic shock and mortality in acute coronary syndromes.
    Eur Heart J. 2023;44:3859-3871.
    PubMed     Abstract available
    
    
    
79. NISSEN SE
    Plaque morphology, inflammation, and outcome: cautious and tempered interpretation warranted.
    Eur Heart J. 2023;44:3926-3928.
    PubMed    
    
    
    
80. GERHARDT T, Seppelt C, Abdelwahed YS, Meteva D, et al
    Culprit plaque morphology determines inflammatory risk and clinical outcomes in acute coronary syndrome.
    Eur Heart J. 2023;44:3911-3925.
    PubMed     Abstract available
    
    
    
81. METEVA D, Vinci R, Seppelt C, Abdelwahed YS, et al
    Toll-like receptor 2, hyaluronan, and neutrophils play a key role in plaque erosion: the OPTICO-ACS study.
    Eur Heart J. 2023;44:3892-3907.
    PubMed     Abstract available
    
    
    
82. FRANCK G
    Unravelling the heart's comic drama: can TLRs and hyaluronan metabolism stoke neutrophil rage in acute coronary syndrome?
    Eur Heart J. 2023;44:3908-3910.
    PubMed    
    
    
    
83. EMMERT MY, Burrello J, Wolint P, Hilbe M, et al
    Intracoronary delivery of extracellular vesicles from human cardiac progenitor cells reduces infarct size in porcine acute myocardial infarction.
    Eur Heart J. 2023 Oct 3:ehad636. doi: 10.1093.
    PubMed    
    
    
    
84. PEDICINO D, Liuzzo G
    An unexpected fall from GRACE.
    Eur Heart J. 2023;44:3501-3502.
    PubMed    
    
    
    September 2023
85. VERGALLO R, Volpe M
    Light the FIRE of revascularization in older patients with myocardial infarction.
    Eur Heart J. 2023 Sep 28:ehad638. doi: 10.1093.
    PubMed    
    
    
    
86. KI YJ, Han K, Kim HS, Han JK, et al
    Smoking and cardiovascular outcomes after percutaneous coronary intervention: a Korean study.
    Eur Heart J. 2023 Sep 26:ehad616. doi: 10.1093.
    PubMed     Abstract available
    
    
    
87. WEINTRAUB WS, Boden WE
    Can we measurably improve the prediction of recurrent coronary artery disease events?
    Eur Heart J. 2023;44:3466-3468.
    PubMed    
    
    
    
88. CREA F
    Challenges and opportunities in prognostication: focus on ischaemic heart disease and atrial fibrillation.
    Eur Heart J. 2023;44:3391-3394.
    PubMed    
    
    
    
89. CHO SMJ, Koyama S, Honigberg MC, Surakka I, et al
    Genetic, sociodemographic, lifestyle, and clinical risk factors of recurrent coronary artery disease events: a population-based cohort study.
    Eur Heart J. 2023;44:3456-3465.
    PubMed     Abstract available
    
    
    
90. ARDISSINO M, Morley AP, Slob EAW, Schuermans A, et al
    Birth weight influences cardiac structure, function, and disease risk: evidence of a causal association.
    Eur Heart J. 2023 Sep 20:ehad631. doi: 10.1093.
    PubMed     Abstract available
    
    
    
91. CREA F
    TAVI or non-TAVI in asymptomatic aortic stenosis, in cardiogenic shock, and in patients with Heyde syndrome?
    Eur Heart J. 2023;44:3105-3109.
    PubMed    
    
    
    August 2023
92. BERRY C, McClure JD, Oldroyd KG
    Coronary revascularization guided by instantaneous wave-free ratio compared to fractional flow reserve: pooled 5-year mortality in the DEFINE-FLAIR and iFR-SWEDEHEART trials.
    Eur Heart J. 2023 Aug 27:ehad552. doi: 10.1093.
    PubMed    
    
    
    
93. EFTEKHARI A, Holck EN, Westra J, Olsen NT, et al
    Five-year major cardiovascular events are increased when coronary revascularization is guided by instantaneous wave-free ratio compared to fractional flow reserve: a pooled analysis of iFR-SWEDEHEART and DEFINE-FLAIR trials.
    Eur Heart J. 2023 Aug 27:ehad582. doi: 10.1093.
    PubMed     Abstract available
    
    
    
94. GAUTIER A, Picard F, Ducrocq G, Elbez Y, et al
    New-onset atrial fibrillation in chronic coronary syndrome: the CLARIFY registry.
    Eur Heart J. 2023 Aug 27:ehad556. doi: 10.1093.
    PubMed     Abstract available
    
    
    
95. BYRNE RA, Rossello X, Coughlan JJ, Barbato E, et al
    2023 ESC Guidelines for the management of acute coronary syndromes.
    Eur Heart J. 2023 Aug 25:ehad191. doi: 10.1093.
    PubMed    
    
    
    
96. RAO S, Nazarzadeh M, Canoy D, Li Y, et al
    Sodium-based paracetamol: impact on blood pressure, cardiovascular events, and all-cause mortality.
    Eur Heart J. 2023 Aug 23:ehad535. doi: 10.1093.
    PubMed     Abstract available
    
    
    
97. CAPODANNO D, Angiolillo DJ
    Personalised antiplatelet therapies for coronary artery disease: what the future holds.
    Eur Heart J. 2023;44:3059-3072.
    PubMed     Abstract available
    
    
    
98. AARTS GWA, Camaro C, van Royen N
    Ready for rapid rule-out of acute myocardial infarction.
    Eur Heart J. 2023 Aug 18:ehad519. doi: 10.1093.
    PubMed    
    
    
    
99. MATTER MA, Paneni F, Libby P, Frantz S, et al
    Inflammation in acute myocardial infarction: the good, the bad and the ugly.
    Eur Heart J. 2023 Aug 17:ehad486. doi: 10.1093.
    PubMed     Abstract available
    
    
    
100. PRENDERGAST BD, Patterson T, Redwood S
     Transcatheter aortic valve implantation in patients with severe aortic stenosis and cardiogenic shock: an important step forward.
     Eur Heart J. 2023 Aug 10:ehad471. doi: 10.1093.
     PubMed    
     
     
     
101. CREA F
     Coronary microvascular dysfunction: from Cinderella to Princess.
     Eur Heart J. 2023;44:2791-2794.
     PubMed    
     
     
     
102. KATUS HA, Giannitsis E
     Single high-sensitivity troponin sample below the limit of detection to safely rule out NSTEMI-ACS: is this enough?
     Eur Heart J. 2023;44:2859-2861.
     PubMed    
     
     
     
103. MORROW AJ, McFarlane R, Berry C
     Novel therapy for ischaemia with no obstructive coronary arteries.
     Eur Heart J. 2023;44:2829-2832.
     PubMed    
     
     
     
104. ENDAMENA GB, Le Moal J, Landolff Q
     Fast healing of an almost complete iatrogenic ascending aortic hematoma post-percutaneous recanalization for chronic total occlusion.
     Eur Heart J. 2023;44:2875.
     PubMed    
     
     
     
105. MCENTEGART M, Gori T
     How to treat left main coronary artery disease: the complementary lessons from trials and registries.
     Eur Heart J. 2023;44:2843-2845.
     PubMed    
     
     
     
106. PERSSON J, Yan J, Angeras O, Venetsanos D, et al
     PCI or CABG for left main coronary artery disease: the SWEDEHEART registry.
     Eur Heart J. 2023;44:2833-2842.
     PubMed     Abstract available
     
     
     
107. ACHIM A, Johnson NP, Liblik K, Burckhardt A, et al
     Coronary steal: how many thieves are out there?
     Eur Heart J. 2023;44:2805-2814.
     PubMed     Abstract available
     
     
     
108. AL ZAIDI M, Nickenig G, Zimmer S
     Emergency transcatheter aortic valve replacement in a 35-year-old patient with unicuspid aortic valve disease and cardiogenic shock.
     Eur Heart J. 2023 Aug 2:ehad465. doi: 10.1093.
     PubMed    
     
     
     
109. LIUZZO G, Patrono C
     Acute myocardial infarction is associated with faster age-related cognitive decline.
     Eur Heart J. 2023 Aug 1:ehad475. doi: 10.1093.
     PubMed    
     
     
     
110. VERGALLO R, Patrono C
     Machine learning and myocardial infarction diagnosis: sometimes you can't make it on your own.
     Eur Heart J. 2023 Aug 1:ehad467. doi: 10.1093.
     PubMed    
     
     
     
111. SANCHEZ-CABO F, Fuster V, Silla-Castro JC, Gonzalez G, et al
     Subclinical atherosclerosis and accelerated epigenetic age mediated by inflammation: a multi-omics study.
     Eur Heart J. 2023;44:2698-2709.
     PubMed     Abstract available
     
     
     
112. VAN KLEI WA, van Waes JAR, Beattie WS
     Routine post-operative troponin surveillance after non-cardiac surgery: are we ready?
     Eur Heart J. 2023 Aug 1:ehad487. doi: 10.1093.
     PubMed    
     
     
     
113. ROHDE LE, McMurray JJV
     REVIV(E)ing the ischaemic paradigm in heart failure: STICHes are needed.
     Eur Heart J. 2023 Aug 1:ehad488. doi: 10.1093.
     PubMed    
     
     
     July 2023
114. PEDERSEN CK, Stengaard C, Botker MT, Sondergaard HM, et al
     Accelerated -Rule-Out of acute Myocardial Infarction using prehospital copeptin and in-hospital troponin: The AROMI study.
     Eur Heart J. 2023 Jul 21:ehad447. doi: 10.1093.
     PubMed     Abstract available
     
     
     
115. DE LEMOS JA, Berry JD
     Comparisons of multiple troponin assays for detecting chronic myocardial injury in the general population: redundant or complementary?
     Eur Heart J. 2023;44:2606-2608.
     PubMed    
     
     
     
116. DEL VAL D, Bastante T, Alfonso F
     A novel coronary artery healing pattern suggesting the axial progression of coronary plaques.
     Eur Heart J. 2023;44:2643.
     PubMed    
     
     
     
117. FAZEL R, Yeh RW, Cohen DJ, Rao SV, et al
     Intravascular imaging during percutaneous coronary intervention: temporal trends and clinical outcomes in the USA.
     Eur Heart J. 2023 Jul 19:ehad430. doi: 10.1093.
     PubMed     Abstract available
     
     
     
118. PEDICINO D, Liuzzo G
     Should I stent or should I go?
     Eur Heart J. 2023;44:2425-2426.
     PubMed    
     
     
     
119. CREA F
     Focus on ischaemic heart disease: from mechanisms to prevention and treatment.
     Eur Heart J. 2023;44:2351-2354.
     PubMed    
     
     
     
120. RUSSO M, Rinaldi R, Camilli M, Bonanni A, et al
     Air pollution and plaque healing in acute coronary syndromes.
     Eur Heart J. 2023;44:2403-2405.
     PubMed    
     
     
     
121. FYYAZ S, Papadakis M
     Fit to a fault? The paradox of coronary artery disease in veteran athletes.
     Eur Heart J. 2023;44:2400-2402.
     PubMed    
     
     
     
122. FREITAG MT, Haaf P, Zellweger MJ
     Severe myocardial ischemia detected in routine oncological positron emission tomography/computed tomography with 18F-fluorodeoxyglucose.
     Eur Heart J. 2023;44:2412.
     PubMed    
     
     
     
123. BERRY C, Kramer CM, Kunadian V, Patel TR, et al
     Great Debate: Computed tomography coronary angiography should be the initial diagnostic test in suspected angina.
     Eur Heart J. 2023;44:2366-2375.
     PubMed    
     
     
     
124. DE BOSSCHER R, Dausin C, Claus P, Bogaert J, et al
     Lifelong endurance exercise and its relation with coronary atherosclerosis.
     Eur Heart J. 2023;44:2388-2399.
     PubMed     Abstract available
     
     
     
125. MENTE A, Dehghan M, Rangarajan S, O'Donnell M, et al
     Diet, cardiovascular disease, and mortality in 80 countries.
     Eur Heart J. 2023 Jul 6:ehad269. doi: 10.1093.
     PubMed     Abstract available
     
     
     June 2023
126. BJORNSON E, Adiels M, Taskinen MR, Burgess S, et al
     Triglyceride-rich lipoprotein remnants, low-density lipoproteins, and risk of coronary heart disease: a UK Biobank study.
     Eur Heart J. 2023 Jun 26:ehad337. doi: 10.1093.
     PubMed     Abstract available
     
     
     
127. CANDREVA A, Templin C
     Is Takotsubo syndrome just the tip of the iceberg in the clinical spectrum of coronary microvascular dysfunction?
     Eur Heart J. 2023;44:2254-2256.
     PubMed    
     
     
     
128. DONG F, Yin L, Sisakian H, Hakobyan T, et al
     Takotsubo syndrome is a coronary microvascular disease: experimental evidence.
     Eur Heart J. 2023;44:2244-2253.
     PubMed     Abstract available
     
     
     
129. LOWRY MTH, Doudesis D, Boeddinghaus J, Kimenai DM, et al
     Troponin in early presenters to rule out myocardial infarction.
     Eur Heart J. 2023 Jun 23:ehad376. doi: 10.1093.
     PubMed     Abstract available
     
     
     
130. SOURIJ H, Aziz F, Mangge H, von Lewinski D, et al
     SGLT2 inhibition could potentially impact inflammation in acute myocardial infarction.
     Eur Heart J. 2023 Jun 23:ehad404. doi: 10.1093.
     PubMed    
     
     
     
131. TRIMAILLE A, Marchandot B, Morel O
     Modulation of inflammatory response after myocardial infarction: one explanation for the cardiovascular benefit of empagliflozin in the EMMY trial?
     Eur Heart J. 2023 Jun 23:ehad257. doi: 10.1093.
     PubMed    
     
     
     
132. BOERHOUT CKM, Lee JM, de Waard GA, Mejia-Renteria H, et al
     Microvascular resistance reserve: diagnostic and prognostic performance in the ILIAS registry.
     Eur Heart J. 2023 Jun 23:ehad378. doi: 10.1093.
     PubMed     Abstract available
     
     
     
133. GOEL K, Shah P, Jones BM, Korngold E, et al
     Outcomes of transcatheter aortic valve replacement in patients with cardiogenic shock.
     Eur Heart J. 2023 Jun 23:ehad387. doi: 10.1093.
     PubMed     Abstract available
     
     
     
134. NEMET I, Li XS, Haghikia A, Li L, et al
     Atlas of gut microbe-derived products from aromatic amino acids and risk of cardiovascular morbidity and mortality.
     Eur Heart J. 2023 Jun 21:ehad333. doi: 10.1093.
     PubMed     Abstract available
     
     
     
135. ALEXANDRE A, Silveira J, Sa I
     Chronic intramyocardial dissecting haematoma: multimodality imaging.
     Eur Heart J. 2023;44:2132.
     PubMed    
     
     
     
136. AMIN H, Noor HA, Bardooli F, Yousif N, et al
     Implementation of a national primary percutaneous coronary intervention program for ST-segment elevation myocardial infarction in the Kingdom of Bahrain: an inspiring success story from a centre of excellence.
     Eur Heart J. 2023 Jun 17:ehad329. doi: 10.1093.
     PubMed    
     
     
     
137. SABOURET P, Biondi-Zoccai G, Banach M, Galli M, et al
     Modulation and personalization of therapy after acute coronary syndromes: the road to precision.
     Eur Heart J. 2023;44:1965-1967.
     PubMed    
     
     
     
138. VERGALLO R, Patrono C
     Lower income, higher risk: disparities in treatments and outcomes of patients with acute myocardial infarction.
     Eur Heart J. 2023 Jun 2:ehad348. doi: 10.1093.
     PubMed    
     
     
     May 2023
139. CREA F
     Ischaemic heart disease: from the celebration of Heberden's description of angina pectoris to novel therapeutic targets for angiogenesis and myocardial fibrosis.
     Eur Heart J. 2023;44:1669-1673.
     PubMed    
     
     
     
140. HEUSCH G, Botker HE, Ferdinandy P, Schulz R, et al
     Primordial non-responsiveness: a neglected obstacle to cardioprotection.
     Eur Heart J. 2023;44:1687-1689.
     PubMed    
     
     
     
141. GIGANTE B
     To be or not to be admitted to the emergency department for chest pain? A costly dilemma.
     Eur Heart J. 2023;44:1715-1717.
     PubMed    
     
     
     
142. ZHU D, Liu S, Huang K, Li J, et al
     Intrapericardial long non-coding RNA-Tcf21 antisense RNA inducing demethylation administration promotes cardiac repair.
     Eur Heart J. 2023;44:1748-1760.
     PubMed     Abstract available
     
     
     
143. IDING A, Ten Cate-Hoek A, Ten Cate H
     Determining 'thrombogenicity' in patients with coronary artery disease: what's next?
     Eur Heart J. 2023;44:1729-1731.
     PubMed    
     
     
     
144. NISHI T, Kume T, Uemura S
     Resuscitated sudden cardiac arrest related to intraplaque haemorrhage and coronary artery spasm.
     Eur Heart J. 2023;44:1766.
     PubMed    
     
     
     
145. BAO XL, Dai Y, Lu L, Wang XQ, et al
     Vasostatin-2 associates with coronary collateral vessel formation in diabetic patients and promotes angiogenesis via angiotensin-converting enzyme 2.
     Eur Heart J. 2023;44:1732-1744.
     PubMed     Abstract available
     
     
     
146. CAMARO C, Aarts GWA, Adang EMM, van Hout R, et al
     Rule-out of non-ST-segment elevation acute coronary syndrome by a single, pre-hospital troponin measurement: a randomized trial.
     Eur Heart J. 2023;44:1705-1714.
     PubMed     Abstract available
     
     
     
147. BODEN WE, Kaski JC, Berry C
     Reprising Heberden's description of angina pectoris after 250 years.
     Eur Heart J. 2023;44:1684-1686.
     PubMed    
     
     
     
148. EMRICH T, Hell M
     Plaque composition on ultra-high-resolution coronary computed tomography angiography with optical coherence tomography correlation.
     Eur Heart J. 2023;44:1765.
     PubMed    
     
     
     
149. VERGALLO R, Patrono C
     'Atom Heart Mothers': the risk of ischaemic heart disease in women with adverse pregnancy outcomes.
     Eur Heart J. 2023;44:1592-1593.
     PubMed    
     
     
     
150. HAN Y
     Chinese expert consensus on clinical application of percutaneous mechanical circulatory support devices in interventional therapy for patients with complex cardiovascular disease.
     Eur Heart J. 2023;44:1586-1588.
     PubMed    
     
     
     
151. UEMATSU M, Yamada R, Sato A
     Isolated septal myocardial infarction with non-obstructive coronary arteries.
     Eur Heart J. 2023 May 4:ehad252. doi: 10.1093.
     PubMed    
     
     
     April 2023
152. BEN-BARUCH GOLAN Y, Zahger D
     Routine troponin testing before non-cardiac surgery: does the evidence justify the consequences?
     Eur Heart J. 2023 Apr 26:ehad227. doi: 10.1093.
     PubMed    
     
     
     
153. VERGALLO R, Liuzzo G
     Intravascular imaging to guide percutaneous coronary intervention of complex lesions: time to renovate guidelines?
     Eur Heart J. 2023 Apr 26:ehad243. doi: 10.1093.
     PubMed    
     
     
     
154. LIAKOPOULOS OJ, Kuhn EW, Hellmich M, Schlomicher M, et al
     Statin loading before coronary artery bypass grafting: a randomized trial.
     Eur Heart J. 2023 Apr 22:ehad238. doi: 10.1093.
     PubMed     Abstract available
     
     
     
155. GENEST J
     Transient very low LDL-C levels: a legacy effect for cardiovascular prevention?
     Eur Heart J. 2023;44:1418-1420.
     PubMed    
     
     
     
156. WADSTROM BN, Pedersen KM, Wulff AB, Nordestgaard BG, et al
     Elevated remnant cholesterol, plasma triglycerides, and cardiovascular and non-cardiovascular mortality.
     Eur Heart J. 2023;44:1432-1445.
     PubMed     Abstract available
     
     
     
157. CREA F
     Persistent challenges following percutaneous interventions: paravalvular regurgitation, in-stent restenosis, and antiplatelet treatment-related bleeding.
     Eur Heart J. 2023;44:1287-1290.
     PubMed    
     
     
     
158. KANG J, Rizas KD, Park KW, Chung J, et al
     Dual antiplatelet therapy de-escalation in acute coronary syndrome: an individual patient meta-analysis.
     Eur Heart J. 2023;44:1360-1370.
     PubMed     Abstract available
     
     
     
159. NDREPEPA G, Kastrati A
     P2Y12 inhibitor intensity de-escalation in patients with acute coronary syndromes.
     Eur Heart J. 2023;44:1371-1373.
     PubMed    
     
     
     
160. GIACOPPO D, Alvarez-Covarrubias HA, Koch T, Cassese S, et al
     Coronary artery restenosis treatment with plain balloon, drug-coated balloon, or drug-eluting stent: 10-year outcomes of the ISAR-DESIRE 3 trial.
     Eur Heart J. 2023;44:1343-1357.
     PubMed     Abstract available
     
     
     
161. GENTILE D, Iannaccone M, Chieffo A
     Drug-coated balloons: from treatment of in-stent restenosis to extended indications. What's next?
     Eur Heart J. 2023;44:1357-1359.
     PubMed    
     
     
     
162. FEDELE D, Foa A, Pizzi C
     Electrocardiographic tips in a young woman presenting with ST-elevation myocardial infarction.
     Eur Heart J. 2023 Apr 11:ehad178. doi: 10.1093.
     PubMed    
     
     
     
163. COLOMBO A, Leone PP
     Redefining the way to perform percutaneous coronary intervention: a view in search of evidence.
     Eur Heart J. 2023 Apr 11:ehad215. doi: 10.1093.
     PubMed    
     
     
     
164. PEDICINO D, Volpe M
     Higher hospital readmissions in blacks after acute myocardial infarction: healthcare inequality gaps to fill in secondary prevention.
     Eur Heart J. 2023 Apr 10:ehad179. doi: 10.1093.
     PubMed    
     
     
     
165. HIRANO KI, Higashi M, Nakajima K
     Remarkable regression of diffuse coronary atherosclerosis in patients with triglyceride deposit cardiomyovasculopathy.
     Eur Heart J. 2023;44:1191.
     PubMed    
     
     
     March 2023
166. NURMOHAMED NS, Kraaijenhof JM, Mayr M, Nicholls SJ, et al
     Proteomics and lipidomics in atherosclerotic cardiovascular disease risk prediction.
     Eur Heart J. 2023 Mar 29:ehad161. doi: 10.1093.
     PubMed     Abstract available
     
     
     
167. SAKAI K, Collet C, Matsuo H
     Improvement of angina after treating focal coronary artery disease undetected in resting conditions.
     Eur Heart J. 2023;44:1097.
     PubMed    
     
     
     
168. LIUZZO G, Patrono C
     Allopurinol does not improve cardiovascular outcomes in ischaemic heart disease.
     Eur Heart J. 2023;44:1016-1017.
     PubMed    
     
     
     
169. CIARDETTI N, Nardi G, Di Mario C
     Direct high-frequency intravascular ultrasound visualization of drug delivery after paclitaxel urea eluting balloon angioplasty.
     Eur Heart J. 2023;44:1096.
     PubMed    
     
     
     
170. HONDA Y, Nishihira K, Shibata Y, Asada Y, et al
     Early-phase restenosis following directional coronary atherectomy and paclitaxel-coated balloon angioplasty: a histopathological analysis.
     Eur Heart J. 2023;44:1098.
     PubMed    
     
     
     
171. THIELE H, Desch S, Freund A
     Out-of-hospital cardiac arrest without ST-segment elevation: an alternative focus on priorities?
     Eur Heart J. 2023;44:1055-1057.
     PubMed    
     
     
     
172. JIANG Y, Huang J, Li G, Wang W, et al
     Ozone pollution and hospital admissions for cardiovascular events.
     Eur Heart J. 2023 Mar 10:ehad091. doi: 10.1093.
     PubMed     Abstract available
     
     
     
173. OZKAN J
     Patient study highlights the need to talk about INOCA.
     Eur Heart J. 2023;44:788-789.
     PubMed    
     
     
     
174. SHEMESH E, Chevli PA, Islam T, German CA, et al
     Circulating ketone bodies and cardiovascular outcomes: the MESA study.
     Eur Heart J. 2023 Mar 6:ehad087. doi: 10.1093.
     PubMed     Abstract available
     
     
     
175. LEE SH, Kim HK, Ahn JH, Kang MG, et al
     Prognostic impact of hypercoagulability and impaired fibrinolysis in acute myocardial infarction.
     Eur Heart J. 2023 Mar 1:ehad088. doi: 10.1093.
     PubMed     Abstract available
     
     
     
176. HOJO K, Otsuka K, Kasayuki N
     Plaque rupture after coronary CT angiography.
     Eur Heart J. 2023;44:782.
     PubMed    
     
     
     
177. MAJMUNDAR M, Doshi R, Patel KN, Zala H, et al
     Prevalence, trends, and outcomes of cardiovascular diseases in pregnant patients in the USA: 2010-19.
     Eur Heart J. 2023;44:726-737.
     PubMed     Abstract available
     
     
     February 2023
178. 
     Corrigendum to: Climate and environmental triggers of acute myocardial infarction.
     Eur Heart J. 2023 Feb 25:ehad105. doi: 10.1093.
     PubMed    
     
     
     
179. THOMAS PE, Vedel-Krogh S, Kamstrup PR, Nordestgaard BG, et al
     Lipoprotein(a) is linked to atherothrombosis and aortic valve stenosis independent of C-reactive protein.
     Eur Heart J. 2023 Feb 21:ehad055. doi: 10.1093.
     PubMed     Abstract available
     
     
     
180. DIBBEN GO, Faulkner J, Oldridge N, Rees K, et al
     Exercise-based cardiac rehabilitation for coronary heart disease: a meta-analysis.
     Eur Heart J. 2023;44:452-469.
     PubMed     Abstract available
     
     
     
181. CREA F
     Optimal management of myocardial infarction: from invasive treatment to secondary prevention and rehabilitation.
     Eur Heart J. 2023;44:431-434.
     PubMed    
     
     
     
182. GRACE SL
     Evidence is indisputable that cardiac rehabilitation provides health benefits and event reduction: time for policy action.
     Eur Heart J. 2023;44:470-472.
     PubMed    
     
     
     
183. MEHTA SR, McGrath BP
     Anatomy vs. physiology: how should we achieve complete revascularization in acute coronary syndromes?
     Eur Heart J. 2023;44:485-487.
     PubMed    
     
     
     
184. PRICE S, Kaski JC, Al-Lamee R, Boden WE, et al
     The year in cardiovascular medicine 2022: the top 10 papers in acute cardiac care and ischaemic heart disease.
     Eur Heart J. 2023;44:445-447.
     PubMed    
     
     
     
185. MORROW DA
     Prognostic interpretation of serial high-sensitivity cardiac troponin in patients presenting with suspected acute coronary syndrome.
     Eur Heart J. 2023;44:513-515.
     PubMed    
     
     
     
186. PAREEK M, Kragholm KH, Kristensen AMD, Vaduganathan M, et al
     Serial troponin-T and long-term outcomes in suspected acute coronary syndrome.
     Eur Heart J. 2023;44:502-512.
     PubMed     Abstract available
     
     
     
187. YAMAMOTO H, Fujii M, Takaya T
     High-risk calcified plaque preoperatively detected by non-contrast T1-weighted magnetic resonance imaging and electrocardiogram-gated computed tomography.
     Eur Heart J. 2023;44:534.
     PubMed    
     
     
     
188. OZKAN J
     Small country big difference: how one physician's vision became a reality and transformed acute myocardial infarction management in the Republic of Mauritius.
     Eur Heart J. 2023 Feb 3:ehad012. doi: 10.1093.
     PubMed    
     
     
     
189. THYGESEN K, Jaffe AS
     Potential risks of non-cardiac peri-operative myocardial infarction/injury.
     Eur Heart J. 2023 Feb 1:ehac768. doi: 10.1093.
     PubMed    
     
     
     
190. GERSH BJ, De Mets D
     Revascularization in ischaemic cardiomyopathy: how to interpret current evidence.
     Eur Heart J. 2023;44:365-367.
     PubMed    
     
     
     
191. VERGALLO R, Volpe M
     A gender issue in the diagnostic imaging work-up of stable coronary artery disease? Insights from DISCHARGE.
     Eur Heart J. 2023;44:340-341.
     PubMed    
     
     
     January 2023
192. PUELACHER C, Gualandro DM, Glarner N, Lurati Buse G, et al
     Long-term outcomes of perioperative myocardial infarction/injury after non-cardiac surgery.
     Eur Heart J. 2023 Jan 27:ehac798. doi: 10.1093.
     PubMed     Abstract available
     
     
     
193. CREA F
     Ischaemic heart disease: antithrombotic treatment and new therapeutic targets.
     Eur Heart J. 2023;44:239-242.
     PubMed    
     
     
     
194. KATO ET, Morrow DA, Guo J, Berg DD, et al
     Growth differentiation factor 15 and cardiovascular risk: individual patient meta-analysis.
     Eur Heart J. 2023;44:293-300.
     PubMed     Abstract available
     
     
     
195. GALLI M, Ortega-Paz L, Angiolillo DJ
     Oral P2Y12 inhibiting therapy in patients with acute coronary syndrome: finding the sweet spot.
     Eur Heart J. 2023;44:236.
     PubMed    
     
     
     
196. XIE C, Zhang Y, Lin J
     Are there other factors that influence the assessment of bleeding risk comparing potent P2Y12 inhibitors with clopidogrel?
     Eur Heart J. 2023;44:235.
     PubMed    
     
     
     
197. CREA F
     Hot topics in ischaemic heart disease: polygenic risk scores, coronary microvascular dysfunction, myocardial injury, and diagnostic role of imaging.
     Eur Heart J. 2023;44:73-76.
     PubMed    
     
     
     
198. NEGLIA D, Liga R, Gimelli A, Podlesnikar T, et al
     Use of cardiac imaging in chronic coronary syndromes: the EURECA Imaging registry.
     Eur Heart J. 2023;44:142-158.
     PubMed     Abstract available
     
     
     
199. PEPINE CJ, Bairey Merz CN
     Heart and brain interactions: is small vessel disease a link?
     Eur Heart J. 2023;44:126-128.
     PubMed    
     
     
     
200. MEJIA-RENTERIA H, Travieso A, Matias-Guiu JA, Yus M, et al
     Coronary microvascular dysfunction is associated with impaired cognitive function: the Cerebral-Coronary Connection study (C3 study).
     Eur Heart J. 2023;44:113-125.
     PubMed     Abstract available
     
     
     
201. RAY KK, Raal FJ, Kallend DG, Jaros MJ, et al
     Inclisiran and cardiovascular events: a patient-level analysis of phase III trials.
     Eur Heart J. 2023;44:129-138.
     PubMed     Abstract available
     
     
     
202. OMRAN H
     Troponin for risk stratification after CABG: just one piece of the puzzle.
     Eur Heart J. 2023;44:163-164.
     PubMed    
     
     
     
203. CHEN T, Zhou H, Guo J, Chen Y, et al
     Intravascular ultrasound and ultrasonic flow ratio-guided zero-contrast rotational atherectomy for calcified coronary lesions.
     Eur Heart J. 2023;44:166.
     PubMed    
     
     
     December 2022
204. TARDIF JC, Pfeffer MA, Dube MP
     Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome.
     Eur Heart J. 2022;43:5062-5063.
     PubMed    
     
     
     
205. SNIDERMAN AD
     dal-GenE was negative-not positive except for COVID-19.
     Eur Heart J. 2022;43:5061.
     PubMed    
     
     
     
206. FUKAMACHI D, Okumura Y
     Growing giant coronary artery aneurysm.
     Eur Heart J. 2022;43:5065.
     PubMed    
     
     
     
207. HUBER K
     Platelet antiaggregation after an acute coronary syndrome: what about the elderly?
     Eur Heart J. 2022;43:5045-5046.
     PubMed    
     
     
     
208. GIBLETT JP, Matetic A, Jenkins D, Ng CY, et al
     Post-infarction ventricular septal defect: percutaneous or surgical management in the UK national registry.
     Eur Heart J. 2022;43:5020-5032.
     PubMed     Abstract available
     
     
     
209. ALFONSO F, Aguilar R, Reyes G
     Management of post-infarction ventricular septal defects: are we moving forward?
     Eur Heart J. 2022;43:5033-5036.
     PubMed    
     
     
     
210. LEE JM, Kim HK, Park KH, Choo EH, et al
     Fractional flow reserve versus angiography-guided strategy in acute myocardial infarction with multivessel disease: a randomized trial.
     Eur Heart J. 2022 Dec 20:ehac763. doi: 10.1093.
     PubMed     Abstract available
     
     
     
211. DANCHIN N
     Improved long-term survival after acute myocardial infarction: the success of comprehensive care from the acute stage to the long term.
     Eur Heart J. 2022 Dec 20:ehac714. doi: 10.1093.
     PubMed    
     
     
     
212. DAVIDSON JA, Banerjee A, Douglas I, Leyrat C, et al
     Primary prevention of acute cardiovascular events by influenza vaccination: an observational study.
     Eur Heart J. 2022 Dec 20:ehac737. doi: 10.1093.
     PubMed     Abstract available
     
     
     
213. COUGHLAN JJ, Ibanez B
     Reperfusion in ST-elevation myocardial infarction: delays have dangerous ends.
     Eur Heart J. 2022 Dec 14:ehac723. doi: 10.1093.
     PubMed    
     
     
     
214. HOLMSTROM L, Juntunen S, Vahatalo J, Pakanen L, et al
     Plaque histology and myocardial disease in sudden coronary death: the Fingesture study.
     Eur Heart J. 2022;43:4923-4930.
     PubMed     Abstract available
     
     
     
215. NISHIHIRA K, Shibata Y, Asada Y
     Intraplaque haemorrhage in rapidly progressing coronary atheroma: insights from histopathological analysis of atherectomy specimens.
     Eur Heart J. 2022;43:4964.
     PubMed    
     
     
     
216. VERGALLO R, Patrono C
     A BRIGHT outlook for bivalirudin in patients with ST-segment elevation myocardial infarction.
     Eur Heart J. 2022 Dec 7:ehac732. doi: 10.1093.
     PubMed    
     
     
     
217. O'SULLIVAN JW, Ashley EA, Elliott PM
     Polygenic risk scores for the prediction of cardiometabolic disease.
     Eur Heart J. 2022 Dec 7:ehac648. doi: 10.1093.
     PubMed     Abstract available
     
     
     
218. EL-CHOULI M, Meddis A, Christensen DM, Gerds TA, et al
     Lifetime risk of comorbidity in patients with simple congenital heart disease: a Danish nationwide study.
     Eur Heart J. 2022 Dec 7:ehac727. doi: 10.1093.
     PubMed     Abstract available
     
     
     
219. COSTA F, Montalto C, Branca M, Hong SJ, et al
     Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials.
     Eur Heart J. 2022 Dec 7:ehac706. doi: 10.1093.
     PubMed     Abstract available
     
     
     
220. LIBERALE L, Puspitasari YM, Ministrini S, Akhmedov A, et al
     JCAD promotes arterial thrombosis through PI3K/Akt modulation: a translational study.
     Eur Heart J. 2022 Dec 5:ehac641. doi: 10.1093.
     PubMed     Abstract available
     
     
     
221. JAMAL J, Idris H, Faour A, Yang W, et al
     Late outcomes of ST-elevation myocardial infarction treated by pharmaco-invasive or primary percutaneous coronary intervention.
     Eur Heart J. 2022 Dec 2:ehac661. doi: 10.1093.
     PubMed     Abstract available
     
     
     
222. HAN Y
     Chinese guidelines for percutaneous coronary intervention in patients with left main bifurcation disease.
     Eur Heart J. 2022 Dec 2:ehac625. doi: 10.1093.
     PubMed    
     
     
     
223. PEDICINO D, Liuzzo G
     Mind the map: a multi-omic approach to post-ischaemic cardiac remodelling paves the way for future cardiovascular research.
     Eur Heart J. 2022;43:4677-4678.
     PubMed    
     
     
     
224. LECOEUR E, Domenge O, Fayol A, Jannot AS, et al
     Epidemiology of heart failure in young adults: a French nationwide cohort study.
     Eur Heart J. 2022 Dec 1:ehac651. doi: 10.1093.
     PubMed     Abstract available
     
     
     November 2022
225. CHRISTENSEN DM, Schjerning AM, Smedegaard L, Charlot MG, et al
     Long-term mortality, cardiovascular events, and bleeding in stable patients 1 year after myocardial infarction: a Danish nationwide study.
     Eur Heart J. 2022 Nov 26:ehac667. doi: 10.1093.
     PubMed     Abstract available
     
     
     
226. HAXHA S, Halili A, Malmborg M, Pedersen-Bjergaard U, et al
     Type 2 diabetes mellitus and higher rate of complete atrioventricular block: a Danish Nationwide Registry.
     Eur Heart J. 2022 Nov 26:ehac662. doi: 10.1093.
     PubMed     Abstract available
     
     
     
227. CREA F
     Controversies in cardiac surgery: left main coronary disease, arterial myocardial revascularization, and prosthetic valves in dialysis.
     Eur Heart J. 2022;43:4603-4605.
     PubMed    
     
     
     
228. KITE TA, Bountziouka V, Ladwiniec A
     Timing of invasive strategy in non-ST-elevation acute coronary syndrome: risk and reward?
     Eur Heart J. 2022;43:4661.
     PubMed    
     
     
     
229. ALADIN AI, Zhang C, Waksman R
     Timing of early invasive strategy in patients with non-ST-elevation acute coronary syndrome.
     Eur Heart J. 2022;43:4660.
     PubMed    
     
     
     
230. GONG X, Shen J, Liu L, Xiao Z, et al
     Pulmonary trunk compression due to multiple aneurysms associated with a coronary-pulmonary artery fistula.
     Eur Heart J. 2022;43:4662.
     PubMed    
     
     
     
231. TAGGART DP, Audisio K, Gerry S, Robinson NB, et al
     Single versus multiple arterial grafting in diabetic patients at 10 years: the Arterial Revascularization Trial.
     Eur Heart J. 2022;43:4644-4652.
     PubMed     Abstract available
     
     
     
232. HOLMSTROM L, Chugh SS
     How to minimize in-hospital mortality from acute myocardial infarction: focus on primary prevention of ventricular fibrillation.
     Eur Heart J. 2022 Nov 15. pii: 6827956. doi: 10.1093.
     PubMed    
     
     
     
233. VAN DEN BROEK WWA, Ten Berg JM
     Is a genotype-guided therapy the optimal strategy to personalize anti-thrombotic management in patients with acute coronary syndrome?
     Eur Heart J. 2022;43:4599-4600.
     PubMed    
     
     
     
234. BONACA MP, Im K, Magnani G, Bansilal S, et al
     Patient selection for long-term secondary prevention with ticagrelor: insights from PEGASUS-TIMI 54.
     Eur Heart J. 2022 Nov 11. pii: 6823782. doi: 10.1093.
     PubMed     Abstract available
     
     
     
235. PATHAK S, Lai FY, Miksza J, Petrie MC, et al
     Surgical or Percutaneous Coronary Revascularisation for Heart Failure: An In Silico Model using Routinely Collected Health Data to Emulate a Clinical Trial.
     Eur Heart J. 2022 Nov 9. pii: 6815617. doi: 10.1093.
     PubMed     Abstract available
     
     
     
236. HEUTS S, Gollmann-Tepekoylu C, Denessen EJS, Olsthoorn JR, et al
     Cardiac troponin release following coronary artery bypass grafting: mechanisms and clinical implications.
     Eur Heart J. 2022 Nov 7. pii: 6807330. doi: 10.1093.
     PubMed     Abstract available
     
     
     
237. FONSECA HAR, Furtado RHM, Zimerman A, Lemos PA, et al
     Influenza vaccination strategy in acute coronary syndromes: the VIP-ACS trial.
     Eur Heart J. 2022;43:4378-4388.
     PubMed     Abstract available
     
     
     
238. VARDENY O
     Influenza vaccine in cardiovascular disease: time to move the needle.
     Eur Heart J. 2022;43:4389-4391.
     PubMed    
     
     
     October 2022
239. GARCIA R, Marijon E, Karam N, Narayanan K, et al
     Ventricular fibrillation in acute myocardial infarction: 20-year trends in the FAST-MI study.
     Eur Heart J. 2022 Oct 28. pii: 6776117. doi: 10.1093.
     PubMed     Abstract available
     
     
     
240. HEYNE S, Macherey S, Meertens MM, Braumann S, et al
     Coronary angiography after cardiac arrest without ST-elevation myocardial infarction: a network meta-analysis.
     Eur Heart J. 2022 Oct 27. pii: 6775293. doi: 10.1093.
     PubMed     Abstract available
     
     
     
241. VERGALLO R, Volpe M
     Fractional flow reserve or intravascular ultrasound for guiding percutaneous coronary intervention of intermediate coronary stenoses? Sometimes apples and oranges have the same FLAVOUR.
     Eur Heart J. 2022 Oct 26. pii: 6774407. doi: 10.1093.
     PubMed    
     
     
     
242. XIAO Q, Pu X, Wei X, Chen M, et al
     Refractory cardiogenic shock in a senile atrial fibrillation patient after left atrial appendage occlusion.
     Eur Heart J. 2022 Oct 17. pii: 6761762. doi: 10.1093.
     PubMed    
     
     
     
243. TYBJAERG-HANSEN A, Nordestgaard LT, Christoffersen M
     Pharmacogenetics-guided CETP inhibition: an open question?
     Eur Heart J. 2022;43:3957-3959.
     PubMed    
     
     
     
244. TARDIF JC, Pfeffer MA, Kouz S, Koenig W, et al
     Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome: the dal-GenE trial.
     Eur Heart J. 2022;43:3947-3956.
     PubMed     Abstract available
     
     
     
245. VERGALLO R, Liuzzo G
     The REVIVED-BCIS2 trial: percutaneous coronary intervention vs. optimal medical therapy for stable patients with severe ischaemic cardiomyopathy.
     Eur Heart J. 2022 Oct 10. pii: 6754626. doi: 10.1093.
     PubMed    
     
     
     
246. VERGALLO R, Liuzzo G
     Coronary artery calcium scoring for cardiovascular risk stratification: more pitfalls than advantages?
     Eur Heart J. 2022;43:3510-3511.
     PubMed    
     
     
     
247. GOTO S, Goto S
     Potent antithrombotic treatments in Asian vs. non-Asian patients.
     Eur Heart J. 2022;43:3553-3555.
     PubMed    
     
     
     
248. HORI M, Zhu J, Liang Y, Bhatt DL, et al
     Rivaroxaban and aspirin vs. aspirin alone in Asian compared with non-Asian patients with chronic coronary artery disease or peripheral arterial disease: the COMPASS trial.
     Eur Heart J. 2022;43:3542-3552.
     PubMed     Abstract available
     
     
     September 2022
249. ARMSTRONG PW, Bates ER, Gaudino M
     Left main coronary disease: evolving management concepts.
     Eur Heart J. 2022 Sep 29. pii: 6731216. doi: 10.1093.
     PubMed     Abstract available
     
     
     
250. HESS CN, Bonaca MP
     Risk of remnants and remnant risk in peripheral artery disease.
     Eur Heart J. 2022;43:3270-3272.
     PubMed    
     
     
     
251. MARQUINA C, Lacaze P, Tiller J, Riaz M, et al
     Population genomic screening of young adults for familial hypercholesterolaemia: a cost-effectiveness analysis.
     Eur Heart J. 2022;43:3243-3254.
     PubMed     Abstract available
     
     
     
252. VERGALLO R, Pedicino D
     Which mechanical circulatory support device in acute myocardial infarction complicated by cardiogenic shock?
     Eur Heart J. 2022 Sep 6. pii: 6692466. doi: 10.1093.
     PubMed    
     
     
     
253. CREA F
     Non-invasive diagnosis, antithrombotic treatment, and invasive management of ischaemic heart disease.
     Eur Heart J. 2022;43:3087-3091.
     PubMed    
     
     
     
254. NADARAJAH R, Wu J, Hurdus B, Asma S, et al
     The collateral damage of COVID-19 to cardiovascular services: a meta-analysis.
     Eur Heart J. 2022;43:3164-3178.
     PubMed     Abstract available
     
     
     
255. SPIRITO A, Cao D, Mehran R
     Subjective angina or myocardial ischaemia to justify PCI? Never mistake the finger for the moon.
     Eur Heart J. 2022;43:3145-3147.
     PubMed    
     
     
     
256. LANCELLOTTI P, Go YY, Nchimi A
     Stress imaging versus fractional flow reserve: what comes first-the chicken or the egg?
     Eur Heart J. 2022;43:3129-3131.
     PubMed    
     
     
     
257. DRIESSEN RS, van Diemen PA, Raijmakers PG, Knuuti J, et al
     Functional stress imaging to predict abnormal coronary fractional flow reserve: the PACIFIC 2 study.
     Eur Heart J. 2022;43:3118-3128.
     PubMed     Abstract available
     
     
     
258. KITE TA, Kurmani SA, Bountziouka V, Cooper NJ, et al
     Timing of invasive strategy in non-ST-elevation acute coronary syndrome: a meta-analysis of randomized controlled trials.
     Eur Heart J. 2022;43:3148-3161.
     PubMed     Abstract available
     
     
     
259. GUEDENEY P, Thiele H, Collet JP
     Timing of invasive management of NSTE-ACS: is the time up for early management?
     Eur Heart J. 2022;43:3161-3163.
     PubMed    
     
     
     August 2022
260. VON LEWINSKI D, Kolesnik E, Tripolt NJ, Pferschy PN, et al
     Empagliflozin in acute Myocardial Infarction: the EMMY trial.
     Eur Heart J. 2022 Aug 29. pii: 6677315. doi: 10.1093.
     PubMed     Abstract available
     
     
     
261. HARRINGTON J, Anker S, Butler J
     Putting the Puzzle Together: SGLT2 Inhibitors from Prevention to Treatment of Heart Failure.
     Eur Heart J. 2022 Aug 29. pii: 6677316. doi: 10.1093.
     PubMed    
     
     
     
262. GIDDING SS, Colangelo LA, Nwabuo CC, Lewis CE, et al
     PDAY risk score predicts cardiovascular events in young adults: the CARDIA study.
     Eur Heart J. 2022;43:2892-2900.
     PubMed     Abstract available
     
     
     July 2022
263. DOLEJSI T, Delgobo M, Schuetz T, Tortola L, et al
     Adult T-cells impair neonatal cardiac regeneration.
     Eur Heart J. 2022;43:2698-2709.
     PubMed     Abstract available
     
     
     
264. 
     Corrigendum to: Temporal trends in bleeding events in acute myocardial infarction: insights from the SWEDEHEART registry.
     Eur Heart J. 2022 Jul 6. pii: 6632321. doi: 10.1093.
     PubMed    
     
     
     
265. GAUDINO M, Farkouh ME, Stone GW
     Left main revascularization: an evidence-based reconciliation.
     Eur Heart J. 2022;43:2421-2424.
     PubMed    
     
     
     
266. FISCHER J, Godecke A, Kelm M, Heusch G, et al
     Master switches in cardiac ischaemia: the Collaborative Research Center (CRC) 1116 of the German Research Foundation.
     Eur Heart J. 2022;43:2350-2351.
     PubMed    
     
     
     June 2022
267. CREA F
     Antiplatelet treatment of acute coronary syndromes: novel clinical and translational perspectives.
     Eur Heart J. 2022;43:2253-2256.
     PubMed    
     
     
     
268. ZHU H, Chen T, Huang J
     An attempt to better show some results such as the comparison of mortality and major adverse cardiovascular events between the abnormal and normal coronary flow reserve cohorts.
     Eur Heart J. 2022;43:2338-2339.
     PubMed    
     
     
     
269. SCHIELE F, Meneveau N
     NSTEMI management: a fall from GRACE?
     Eur Heart J. 2022;43:2300-2302.
     PubMed    
     
     
     
270. TAKEI Y, Abe N, Bohgaki M, Kasahara H, et al
     Paradoxical enlargement of immunoglobulin G4 (IgG4)-related coronary aneurysms despite controlling serum IgG4 level.
     Eur Heart J. 2022;43:2250.
     PubMed    
     
     
     
271. CACHEUX M, Akar FG
     A novel exosome-based therapy for post-MI arrhythmias.
     Eur Heart J. 2022;43:2157-2159.
     PubMed    
     
     
     May 2022
272. GANESANANTHAN S, Rajkumar CA, Foley M, Thompson D, et al
     Cardiopulmonary exercise testing and efficacy of percutaneous coronary intervention: a substudy of the ORBITA trial.
     Eur Heart J. 2022 May 26. pii: 6593472. doi: 10.1093.
     PubMed     Abstract available
     
     
     
273. VAN VELDHUISEN SL, Gorter TM, van Woerden G, de Boer RA, et al
     Bariatric surgery and cardiovascular disease: a systematic review and meta-analysis.
     Eur Heart J. 2022;43:1955-1969.
     PubMed     Abstract available
     
     
     
274. VALGIMIGLI M, Smits PC, Frigoli E, Bongiovanni D, et al
     Duration of Antiplatelet Therapy After Complex Percutaneous Coronary Intervention In Patients at High Bleeding Risk: a MASTER DAPT trial sub-analysis.
     Eur Heart J. 2022 May 17. pii: 6587125. doi: 10.1093.
     PubMed     Abstract available
     
     
     
275. SPOSITO AC
     Soluble LOX-1 levels during acute coronary syndrome: a potent and multifaceted warning sign for cardiovascular risk.
     Eur Heart J. 2022;43:1861-1863.
     PubMed    
     
     
     
276. KRALER S, Wenzl FA, Georgiopoulos G, Obeid S, et al
     Soluble lectin-like oxidized low-density lipoprotein receptor-1 predicts premature death in acute coronary syndromes.
     Eur Heart J. 2022;43:1849-1860.
     PubMed     Abstract available
     
     
     
277. WANG J, Chen H, Zhang L
     Coronary artery fistula bypassed the left main coronary artery blocked by a large cardiogenic thrombus.
     Eur Heart J. 2022;43:1885.
     PubMed    
     
     
     
278. LU X, Liu Z, Cui Q, Liu F, et al
     A polygenic risk score improves risk stratification of coronary artery disease: a large-scale prospective Chinese cohort study.
     Eur Heart J. 2022;43:1702-1711.
     PubMed     Abstract available
     
     
     
279. HAGEMAN SHJ, McKay AJ, Ueda P, Gunn LH, et al
     Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm.
     Eur Heart J. 2022;43:1715-1727.
     PubMed     Abstract available
     
     
     
280. FRANTZ S, Hundertmark MJ, Schulz-Menger J, Bengel FM, et al
     Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies.
     Eur Heart J. 2022 May 4. pii: 6578707. doi: 10.1093.
     PubMed     Abstract available
     
     
     April 2022
281. CREA F
     Inflammation, targeted proteomics, and microvascular dysfunction: the new frontiers of ischaemic heart disease.
     Eur Heart J. 2022;43:1517-1520.
     PubMed    
     
     
     
282. STEFFENS S, Nahrendorf M, Madonna R
     Immune cells in cardiac homeostasis and disease: emerging insights from novel technologies.
     Eur Heart J. 2022;43:1533-1541.
     PubMed     Abstract available
     
     
     
283. KELSHIKER MA, Seligman H, Howard JP, Rahman H, et al
     Coronary flow reserve and cardiovascular outcomes: a systematic review and meta-analysis.
     Eur Heart J. 2022;43:1582-1593.
     PubMed     Abstract available
     
     
     
284. MORICI N, De Servi S, De Luca L, Crimi G, et al
     Management of acute coronary syndromes in older adults.
     Eur Heart J. 2022;43:1542-1553.
     PubMed     Abstract available
     
     
     
285. KELSHIKER MA, Seligman H, Howard JP, Rahman H, et al
     Coronary flow reserve and cardiovascular outcomes: a systematic review and meta-analysis.
     Eur Heart J. 2022;43:1582-1593.
     PubMed     Abstract available
     
     
     
286. HONG S, Kim KS, Han K, Park CY, et al
     Acromegaly and cardiovascular outcomes: a cohort study.
     Eur Heart J. 2022;43:1491-1499.
     PubMed     Abstract available
     
     
     
287. FERNANDEZ ASENSIO R, Pascual Calleja I, Moris de la Tassa C, Colunga Blanco S, et al
     Pneumopericardium mimicking ST-segment elevation acute coronary syndrome.
     Eur Heart J. 2022;43:1516.
     PubMed    
     
     
     
288. SAMMONS E, Hopewell JC, Chen F, Stevens W, et al
     Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease.
     Eur Heart J. 2022;43:1416-1424.
     PubMed     Abstract available
     
     
     
289. BATRA G, Aktaa S, Wallentin L, Maggioni AP, et al
     Data standards for acute coronary syndrome and percutaneous coronary intervention: the European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart).
     Eur Heart J. 2022 Apr 5. pii: 6563567. doi: 10.1093.
     PubMed     Abstract available
     
     
     March 2022
290. BUCCIARELLI-DUCCI C, Ajmone-Marsan N, Di Carli M, Nicol E, et al
     The year in cardiovascular medicine 2021: imaging.
     Eur Heart J. 2022;43:1288-1295.
     PubMed     Abstract available
     
     
     
291. BYRNE RA, Rai H, Colleran R
     Amphilimus-eluting stents in coronary artery disease: finally, a sweet spot for patients with diabetes mellitus?
     Eur Heart J. 2022;43:1331-1333.
     PubMed    
     
     
     
292. HAN Y
     Chinese expert consensus statement on dual antiplatelet therapy in patients with coronary artery disease.
     Eur Heart J. 2022;43:1283-1285.
     PubMed    
     
     
     
293. ROMAGUERA R, Salinas P, Gomez-Lara J, Brugaletta S, et al
     Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: the SUGAR trial.
     Eur Heart J. 2022;43:1320-1330.
     PubMed     Abstract available
     
     
     
294. OKA S, Endo H, Takagi K, Yamagata K, et al
     Mechanical coronary artery stenosis induced by active fixation left ventricular lead: a case of acute complication after cardiac resynchronization therapy device implantation.
     Eur Heart J. 2022;43:1271.
     PubMed    
     
     
     
295. THYGESEN K, Jaffe AS
     Revisiting the definition of perioperative myocardial infarction after coronary artery bypass grafting.
     Eur Heart J. 2022 Mar 17. pii: 6549761. doi: 10.1093.
     PubMed    
     
     
     
296. HAN Y, Li Y
     Adherence to P2Y12 inhibitors in acute coronary syndrome after a percutaneous coronary intervention: what can we improve?
     Eur Heart J. 2022 Mar 17. pii: 6549760. doi: 10.1093.
     PubMed    
     
     
     
297. TURGEON RD, Koshman SL, Dong Y, Graham MM, et al
     P2Y12 inhibitor adherence trajectories in patients with acute coronary syndrome undergoing percutaneous coronary intervention: prognostic implications.
     Eur Heart J. 2022 Mar 17. pii: 6549798. doi: 10.1093.
     PubMed     Abstract available
     
     
     
298. TUAL-CHALOT S, Stellos K
     Chrono-pharmacology-based antiplatelet therapy for acute myocardial infarction.
     Eur Heart J. 2022 Mar 10. pii: 6546087. doi: 10.1093.
     PubMed    
     
     
     
299. DAWKINS JF, Ehdaie A, Rogers R, Soetkamp D, et al
     Biological substrate modification suppresses ventricular arrhythmias in a porcine model of chronic ischaemic cardiomyopathy.
     Eur Heart J. 2022 Mar 9. pii: 6545456. doi: 10.1093.
     PubMed     Abstract available
     
     
     
300. TAN S, White HD, Layland J
     Heparin use in acute coronary syndromes and cardiovascular interventions: habit or evidence based?
     Eur Heart J. 2022;43:1008-1011.
     PubMed    
     
     
     
301. SILVAIN J, Hausenloy D, Zeitouni M
     Appropriate criteria for the definition of Type 4a MI.
     Eur Heart J. 2022;43:1013-1014.
     PubMed    
     
     
     February 2022
302. MOLEDINA SM, Kontopantelis E, Wijeysundera HC, Banerjee S, et al
     Ethnicity-dependent performance of the Global Registry of Acute Coronary Events risk score for prediction of non-ST-segment elevation myocardial infarction in-hospital mortality: nationwide cohort study.
     Eur Heart J. 2022 Feb 24. pii: 6529720. doi: 10.1093.
     PubMed     Abstract available
     
     
     
303. ZENG C, Rosenberg L, Li X, Djousse L, et al
     Sodium-containing acetaminophen and cardiovascular outcomes in individuals with and without hypertension.
     Eur Heart J. 2022 Feb 24. pii: 6535634. doi: 10.1093.
     PubMed     Abstract available
     
     
     
304. PRICE S, Katz J, Kaufmann CC, Huber K, et al
     The year in cardiovascular medicine 2021: acute cardiovascular care and ischaemic heart disease.
     Eur Heart J. 2022;43:800-806.
     PubMed    
     
     
     
305. SHRAUNER W, Lord EM, Nguyen XT, Song RJ, et al
     Frailty and cardiovascular mortality in more than 3 million US Veterans.
     Eur Heart J. 2022;43:818-826.
     PubMed     Abstract available
     
     
     
306. VAROTTO L, De Boni A, Iannucci G, Caprioglio F, et al
     Uncommon intravascular lithotripsy for the treatment of subclavian steal syndrome: a case presenting with concomitant acute coronary syndrome and transient ischaemic attack.
     Eur Heart J. 2022;43:840.
     PubMed    
     
     
     
307. LIUZZO G, Volpe M
     Percutaneous coronary intervention vs. coronary artery bypass graft for left main coronary artery disease: a never-ending debate.
     Eur Heart J. 2022 Feb 21. pii: 6533241. doi: 10.1093.
     PubMed    
     
     
     
308. OMRAN H, Deutsch MA, Groezinger E, Zittermann A, et al
     High-sensitivity cardiac troponin I after coronary artery bypass grafting for post-operative decision-making.
     Eur Heart J. 2022 Feb 15. pii: 6528587. doi: 10.1093.
     PubMed     Abstract available
     
     
     
309. LIUZZO G, Volpe M
     PARADISE-MI suggests a limited role of intensified neuro-hormonal inhibition in the management of acute myocardial infarction with reduced ejection fraction.
     Eur Heart J. 2022;43:559-560.
     PubMed    
     
     
     
310. POLZL L, Thielmann M, Cymorek S, Nagele F, et al
     Impact of myocardial injury after coronary artery bypass grafting on long-term prognosis.
     Eur Heart J. 2022 Feb 9. pii: 6525341. doi: 10.1093.
     PubMed     Abstract available
     
     
     
311. DE CATERINA R, Liga R, Boden WE
     Myocardial revascularization in ischaemic cardiomyopathy: routine practice vs. scientific evidence.
     Eur Heart J. 2022;43:387-390.
     PubMed    
     
     
     January 2022
312. BRAUNWALD E
     How to live to 100 before developing clinical coronary artery disease: a suggestion.
     Eur Heart J. 2022;43:249-250.
     PubMed    
     
     
     
313. SLIWICKA O, Damman P, Habets J
     Stress dynamic CT perfusion in the evaluation of acute coronary syndrome.
     Eur Heart J. 2022;43:244.
     PubMed    
     
     
     
314. CREA F
     Hot topics in ischaemic heart disease: revascularization, hibernation, type 2 infarction, and proteomics.
     Eur Heart J. 2022;43:89-92.
     PubMed    
     
     
     
315. NEWBY LK
     A new biomarker of acute coronary ischaemia: from bench to bedside?
     Eur Heart J. 2022;43:164-166.
     PubMed    
     
     
     
316. RYAN M, Morgan H, Chiribiri A, Nagel E, et al
     Myocardial viability testing: all STICHed up, or about to be REVIVED?
     Eur Heart J. 2022;43:118-126.
     PubMed     Abstract available
     
     
     
317. CUBEDO J, Padro T, Vilahur G, Crea F, et al
     Glycosylated apolipoprotein J in cardiac ischaemia: molecular processing and circulating levels in patients with acute ischaemic events.
     Eur Heart J. 2022;43:153-163.
     PubMed     Abstract available
     
     
     
318. QUADRI G, Tomassini F, Cerrato E, Varbella F, et al
     Emergency treatment of a giant coronary aneurysm: percutaneous intervention with coronary and peripheral tools.
     Eur Heart J. 2022;43:168.
     PubMed    
     
     
     
319. DEMIR OM, Rahman H, van de Hoef TP, Escaned J, et al
     Invasive and non-invasive assessment of ischaemia in chronic coronary syndromes: translating pathophysiology to clinical practice.
     Eur Heart J. 2022;43:105-117.
     PubMed     Abstract available
     
     
     December 2021
320. WANG R, Serruys PW, Gao C, Hara H, et al
     Ten-year all-cause death after percutaneous or surgical revascularization in diabetic patients with complex coronary artery disease.
     Eur Heart J. 2021;43:56-67.
     PubMed     Abstract available
     
     
     
321. NICOLAS J, Giustino G, Dangas G
     Periprocedural myocardial infarction: multiple definitions and still a quest for consensus.
     Eur Heart J. 2021 Dec 21. pii: 6471447. doi: 10.1093.
     PubMed    
     
     
     
322. LOZANO I, Vegas JM, Rondan J
     Percutaneous intervention in patients with cancer: can we offer an improvement in safety?
     Eur Heart J. 2021;42:4981.
     PubMed    
     
     
     
323. WHITE HD, Schwartz GG, Szarek M, Bhatt DL, et al
     Alirocumab after acute coronary syndrome in patients with a history of heart failure.
     Eur Heart J. 2021 Dec 18. pii: 6469637. doi: 10.1093.
     PubMed     Abstract available
     
     
     
324. GALLI M, Benenati S, Franchi F, Rollini F, et al
     Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials.
     Eur Heart J. 2021 Dec 16. pii: 6464193. doi: 10.1093.
     PubMed     Abstract available
     
     
     
325. CREA F
     Percutaneous coronary interventions: more complex than fixing stenoses.
     Eur Heart J. 2021;42:4607-4611.
     PubMed    
     
     
     
326. WHITE HD
     Cardiac death should be the primary endpoint for revascularization trials and meta-analyses.
     Eur Heart J. 2021;42:4697-4698.
     PubMed    
     
     
     
327. AL-LAMEE R, Mintz GS
     What are the PROSPECTs and clinical implications of vulnerable plaque?
     Eur Heart J. 2021;42:4680-4682.
     PubMed    
     
     
     
328. KEDHI E, Berta B, Roleder T, Hermanides RS, et al
     Thin-cap fibroatheroma predicts clinical events in diabetic patients with normal fractional flow reserve: the COMBINE OCT-FFR trial.
     Eur Heart J. 2021;42:4671-4679.
     PubMed     Abstract available
     
     
     
329. AL-LAMEE R, Mintz GS
     What are the PROSPECTs and clinical implications of vulnerable plaque?
     Eur Heart J. 2021;42:4680-4682.
     PubMed    
     
     
     November 2021
330. EGGERS KM, James SK, Lindahl B
     Myocardial infarction after elective percutaneous coronary intervention-which cardiac troponin cut-off to use?
     Eur Heart J. 2021 Nov 24. pii: 6438090. doi: 10.1093.
     PubMed    
     
     
     
331. BOR WL, Ten Berg JM
     Known or new atrial fibrillation in patients with acute coronary syndrome: what's the difference?
     Eur Heart J. 2021;42:4562-4564.
     PubMed    
     
     
     
332. DE SILVA R, Cheng K
     Microvascular angina: quo tendimus?
     Eur Heart J. 2021;42:4601-4604.
     PubMed    
     
     
     
333. SHIMOKAWA H, Suda A, Takahashi J, Berry C, et al
     Clinical characteristics and prognosis of patients with microvascular angina: an international and prospective cohort study by the Coronary Vasomotor Disorders International Study (COVADIS) Group.
     Eur Heart J. 2021;42:4592-4600.
     PubMed     Abstract available
     
     
     
334. PITT B, Ferreira JP, Zannad F
     Why are mineralocorticoid receptor antagonists the Cinderella in evidence-based treatment of myocardial infarction complicated with heart failure? Lessons from PARADISE-MI.
     Eur Heart J. 2021 Nov 12. pii: 6425576. doi: 10.1093.
     PubMed    
     
     
     
335. CHIKWE J, Alfieri OR
     The optimal strategy for multivessel coronary revascularization.
     Eur Heart J. 2021 Nov 11. pii: 6425621. doi: 10.1093.
     PubMed    
     
     
     
336. WINTHER S, Schmidt SE, Knuuti J, Bottcher M, et al
     Selecting the right cohorts and endpoints for the validation of pre-test probability models for obstructive coronary artery disease.
     Eur Heart J. 2021;42:4402-4403.
     PubMed    
     
     
     
337. DERIMAY F, Finet G, Rioufol G
     Coronary artery stenosis prediction does not mean coronary artery stenosis obstruction.
     Eur Heart J. 2021;42:4401.
     PubMed    
     
     
     
338. EGIDY ASSENZA G, Dimopoulos K, Budts W, Donti A, et al
     Management of acute cardiovascular complications in pregnancy.
     Eur Heart J. 2021;42:4224-4240.
     PubMed     Abstract available
     
     
     October 2021
339. BIAN L, Fang Z, Qian H, Wu Z, et al
     Dumbbell on the heart: two giant left coronary artery aneurysms in an adolescent.
     Eur Heart J. 2021;42:4195.
     PubMed    
     
     
     
340. AHN JM, Zimmermann FM, Arora S, Solberg OG, et al
     Prognostic value of comprehensive intracoronary physiology assessment early after heart transplantation.
     Eur Heart J. 2021 Oct 19. pii: 6401958. doi: 10.1093.
     PubMed     Abstract available
     
     
     
341. TSUDA K, Kanzaki Y, Hoshiga M
     Early cardiac magnetic resonance leads to diagnose the etiology of myocardial infarction with non-obstructive coronary arteries.
     Eur Heart J. 2021 Oct 18. pii: 6400298. doi: 10.1093.
     PubMed    
     
     
     
342. WADSTROM BN, Wulff AB, Pedersen KM, Jensen GB, et al
     Elevated remnant cholesterol increases the risk of peripheral artery disease, myocardial infarction, and ischaemic stroke: a cohort-based study.
     Eur Heart J. 2021 Oct 18. pii: 6399975. doi: 10.1093.
     PubMed     Abstract available
     
     
     
343. GALLI M, Angiolillo DJ
     Non-opioid analgesics in patients undergoing percutaneous coronary intervention: hype or hope?
     Eur Heart J. 2021;42:4037-4039.
     PubMed    
     
     
     
344. LECHNER I, Reindl M, Tiller C, Holzknecht M, et al
     Impact of COVID-19 pandemic restrictions on ST-elevation myocardial infarction: a cardiac magnetic resonance imaging study.
     Eur Heart J. 2021 Oct 11. pii: 6386704. doi: 10.1093.
     PubMed     Abstract available
     
     
     
345. BANNING AP, Serruys P, De Maria GL, Ryan N, et al
     Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II study.
     Eur Heart J. 2021 Oct 7. pii: 6383065. doi: 10.1093.
     PubMed     Abstract available
     
     
     
346. CREA F
     The challenge of risk stratification in suspected angina, in myocardial infarction without risk factors, and in frail patients.
     Eur Heart J. 2021;42:3807-3811.
     PubMed    
     
     
     
347. CURZEN N, Nicholas Z, Stuart B, Wilding S, et al
     Fractional flow reserve derived from computed tomography coronary angiography in the assessment and management of stable chest pain: the FORECAST randomized trial.
     Eur Heart J. 2021;42:3844-3852.
     PubMed     Abstract available
     
     
     
348. JAFFER FA, Mehilli J, Escaned J
     Left main coronary disease at the bifurcation: should the pendulum swing back towards the provisional stenting approach?
     Eur Heart J. 2021;42:3840-3843.
     PubMed    
     
     
     
349. SENIOR R, Khattar R
     Stress echocardiography: the quest for risk stratification beyond myocardial ischaemia.
     Eur Heart J. 2021;42:3879-3881.
     PubMed    
     
     
     
350. AVIS SR, Vernon ST, Hagstrom E, Figtree GA, et al
     Coronary artery disease in the absence of traditional risk factors: a call for action.
     Eur Heart J. 2021;42:3822-3824.
     PubMed    
     
     
     
351. MENG SW, Ko TY, Hsieh MY
     Simultaneous acute pulmonary and coronary embolism.
     Eur Heart J. 2021;42:3888.
     PubMed    
     
     
     September 2021
352. HAN Y
     Long-term outcomes of new-generation coronary stents in China.
     Eur Heart J. 2021 Sep 18. pii: 6372216. doi: 10.1093.
     PubMed    
     
     
     
353. SINHA A, Rahman H, Webb A, Shah AM, et al
     Untangling the pathophysiologic link between coronary microvascular dysfunction and heart failure with preserved ejection fraction.
     Eur Heart J. 2021 Sep 16. pii: 6371296. doi: 10.1093.
     PubMed     Abstract available
     
     
     
354. PETERS SAE, Kluin J
     Why do women do worse after coronary artery bypass grafting?
     Eur Heart J. 2021 Sep 15. pii: 6370651. doi: 10.1093.
     PubMed    
     
     
     
355. LOPEZ-SENDON JL, Cyr DD, Mark DB, Bangalore S, et al
     Effects of initial invasive vs. initial conservative treatment strategies on recurrent and total cardiovascular events in the ISCHEMIA trial.
     Eur Heart J. 2021 Sep 13. pii: 6368943. doi: 10.1093.
     PubMed     Abstract available
     
     
     
356. BAYES-GENIS A, Diez J
     Transition to heart failure in hypertension: going to the heart of the matter.
     Eur Heart J. 2021 Sep 13. pii: 6369562. doi: 10.1093.
     PubMed    
     
     
     
357. BROWN JM, Zhou W, Weber B, Divakaran S, et al
     Low coronary flow relative to myocardial mass predicts heart failure in symptomatic hypertensive patients with no obstructive coronary artery disease.
     Eur Heart J. 2021 Sep 7. pii: 6365821. doi: 10.1093.
     PubMed     Abstract available
     
     
     
358. PETERSEN JK, Haider Butt J, Yafasova A, Torp-Pedersen C, et al
     Incidence of ischaemic stroke and mortality in patients with acute coronary syndrome and first-time detected atrial fibrillation: a nationwide study.
     Eur Heart J. 2021 Sep 3. pii: 6363625. doi: 10.1093.
     PubMed     Abstract available
     
     
     August 2021
359. CREA F
     Pulmonary embolism, COVID, and bleeding risk in acute coronary syndromes: a Focus Issue on thrombosis and antithrombotic treatment.
     Eur Heart J. 2021;42:3109-3113.
     PubMed    
     
     
     
360. YANG Q, Sun D, Pei C, Zeng Y, et al
     LDL cholesterol levels and in-hospital bleeding in patients on high-intensity antithrombotic therapy: findings from the CCC-ACS project.
     Eur Heart J. 2021;42:3175-3186.
     PubMed     Abstract available
     
     
     
361. CERRATO E, Giacobbe F, Quadri G, Macaya F, et al
     Antiplatelet therapy in patients with conservatively managed spontaneous coronary artery dissection from the multicentre DISCO registry.
     Eur Heart J. 2021;42:3161-3171.
     PubMed     Abstract available
     
     
     
362. LUSEBRINK E, Massberg S, Orban M
     The lack of evidence-based therapeutic strategies for left ventricular unloading during venoarterial extracorporeal membrane oxygenation therapy calls for randomized trials.
     Eur Heart J. 2021;42:3105-3106.
     PubMed    
     
     
     
363. KLOECKNER M, Guihaire J, Hascoet S
     Congestive pulmonary oedema during venoarterial extracorporeal membrane oxygenation support: a plea for balloon atrial septostomy.
     Eur Heart J. 2021;42:3103-3104.
     PubMed    
     
     
     
364. DAVIERWALA PM, Gao C, Thuijs DJFM, Wang R, et al
     Single or multiple arterial bypass graft surgery vs. percutaneous coronary intervention in patients with three-vessel or left main coronary artery disease.
     Eur Heart J. 2021 Aug 18. pii: 6354120. doi: 10.1093.
     PubMed     Abstract available
     
     
     
365. GAUDINO M, Di Franco A, Alexander JH, Bakaeen F, et al
     Sex differences in outcomes after coronary artery bypass grafting: a pooled analysis of individual patient data.
     Eur Heart J. 2021 Aug 2. pii: 6333765. doi: 10.1093.
     PubMed     Abstract available
     
     
     July 2021
366. KOSYAKOVSKY LB, Austin PC, Ross HJ, Wang X, et al
     Early invasive coronary angiography and acute ischaemic heart failure outcomes.
     Eur Heart J. 2021 Jul 30. pii: 6331345. doi: 10.1093.
     PubMed     Abstract available
     
     
     
367. GOROG DA, Navarese EP, Andreotti F
     Should we consider low LDL-cholesterol a marker of in-hospital bleeding in patients with acute coronary syndrome undergoing percutaneous coronary intervention?
     Eur Heart J. 2021 Jul 29. pii: 6330652. doi: 10.1093.
     PubMed    
     
     
     
368. COLLISON D, Didagelos M, Aetesam-Ur-Rahman M, Copt S, et al
     Post-stenting fractional flow reserve vs coronary angiography for optimisation of percutaneous coronary intervention: TARGET-FFR trial.
     Eur Heart J. 2021 Jul 19. pii: 6323924. doi: 10.1093.
     PubMed     Abstract available
     
     
     May 2021
369. NAVARESE EP, Lansky AJ, Kereiakes DJ, Kubica J, et al
     Cardiac mortality in patients randomised to elective coronary revascularisation plus medical therapy or medical therapy alone: a systematic review and meta-analysis.
     Eur Heart J. 2021 May 18. pii: 6276780. doi: 10.1093.
     PubMed     Abstract available
     
     
     
370. HILDICK-SMITH D, Egred M, Banning A, Brunel P, et al
     The European bifurcation club Left Main Coronary Stent study: a randomized comparison of stepwise provisional vs. systematic dual stenting strategies (EBC MAIN).
     Eur Heart J. 2021 May 18. pii: 6276782. doi: 10.1093.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.